Perrigo To Market Generic Commit Lozenge; Agis Buy Helps Build OTC Sales
This article was originally published in The Tan Sheet
Executive Summary
Perrigo expects to start shipping its private-label equivalents to GSK's Commit nicotine lozenges in early March, the company announced Feb. 2